Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4… Grant US-10052360-B2 United States of America 21 Aug 2018
Methods for treating scleroderma by administering a soluble CTLA4 molecule Grant US-9296808-B2 United States of America 29 Mar 2016
Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule Grant US-8722632-B2 United States of America 13 May 2014
Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule Grant US-8497247-B2 United States of America 30 Jul 2013
Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or… Grant US-8227420-B2 United States of America 24 Jul 2012
Method for treating a rheumatic disease using a soluble TLA4 molecule Grant US-8148332-B2 United States of America 03 Apr 2012
Methods for treating immune disorders associated with graft transplantation with soluble… Grant US-7482327-B2 United States of America 27 Jan 2009
Methods for treating immune system diseases using a soluble CTLA4 molecule Grant US-7455835-B2 United States of America 25 Nov 2008